Hi there,

The climate crisis, war, attacks on reproductive rights, book bans—these threats aren't looming. They are here now. If you think Democracy Now!'s reporting on these issues is essential, please sign up for a monthly gift of $10 or more. Right now, a generous donor will DOUBLE your gift, making your donation twice as valuable. We don't have a paywall or run ads, which means we’re not brought to you by the oil, gas, coal, or nuclear companies when we cover the climate catastrophe or by the weapons manufacturers when we cover war. Democracy Now! is funded by you and that’s why we need your help today. This is a challenging year for news organizations and nonprofits across the board, so please don’t close this window before making your gift. We're counting on you more than ever to sustain our reporting. Start your monthly donation of $10 or more right now and help Democracy Now! stay strong and independent all year round. Thank you so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

Johnson & Johnson Reaches $230 Million Settlement with New York over Role in Opioid Epidemic

HeadlineJun 28, 2021

In other news from New York, Johnson & Johnson has agreed to pay a settlement of up to $230 million over its role in fueling the opioid crisis. Attorney General Letitia James announced that as part of the deal with New York, J&J will no longer manufacture or sell opioids in the U.S. and that the funds from the settlement will go toward prevention, treatment and education efforts in the state. The settlement also allows J&J to escape a major opioid trial starting this week in Long Island, New York.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top